Correction to: Protective effects of dioscin against alcohol‑induced liver injury (Archives of Toxicology, (2013), 10.1007/s00204-013-1148-8);Protective effects of dioscin against alcohol-induced liver injury

Archives of Toxicology

Volumn 88, Issue 3, 2014, Pages 739-753

  Xu, Tingting ^a   Zheng, Lingli ^a   Xu, Lina ^a   Yin, Lianhong ^a   Qi, Yan ^a   Xu, Youwei ^a   Han, Xu ^a   Peng, Jinyong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Dioscin; Ethanol induced liver injury; Fatty acid metabolism; Fatty acid oxidation; TG synthesis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ACYL COENZYME A DEHYDROGENASE; ACYL COENZYME A OXIDASE; ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 9; CYTOCHROME P450 2E1; CYTOKERATIN 18; DIOSCIN; DNA NUCLEOTIDYLEXOTRANSFERASE; GLUCOSE REGULATED PROTEIN 78; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2; INTERLEUKIN 6; LIVER PROTECTIVE AGENT; LONG CHAIN FATTY ACID COENZYME A LIGASE; MALONALDEHYDE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN P53; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DIOSGENIN; FATTY ACID; PROTECTIVE AGENT;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLIC FATTY LIVER; ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL ULTRASTRUCTURE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; DOWN REGULATION; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; LIVER INJURY; LIVER PROTECTION; MALE; MITOCHONDRION; MORPHOLOGY; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FATTY LIVER, ALCOHOLIC; LIVER; LIVER DISEASES, ALCOHOLIC; METABOLISM; PATHOLOGY; TOXICITY TESTING; ULTRASTRUCTURE; WISTAR RAT;

RATTUS;

ANIMALS; CYTOCHROME P-450 CYP2E1; DIOSGENIN; DISEASE MODELS, ANIMAL; ETHANOL; FATTY ACIDS; FATTY LIVER, ALCOHOLIC; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MICE, INBRED C57BL; PROTECTIVE AGENTS; RATS; RATS, WISTAR; TOXICITY TESTS, ACUTE; TOXICITY TESTS, CHRONIC;

EID: 84896715060     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-019-02532-4     Document Type: Erratum

References (76)

1. Ajakaiye MA, Jacob A, Wu R, Zhou M, Ji Y, Dong W, Wang Z, Qiang X, Chaung WW, Nicastro J, Coppa GF, Wang P (2011) Upregulation of Kupffer cell α2A- Adrenoceptors and down regulation of MKP-1 mediate hepatic injury in chronic alcohol exposure. Biochem Biophys Res Commun 409:406-411
2. Aroor AR, James TT, Jackson DE, Shukla SD (2010) Differential changes in MAP kinases, histone modifications, and liver injury in rats acutely treated with ethanol. Alcohol Clin Exp Res 34:1543-1551
3. Arteel GE (2003) Oxidant and antioxidant in alcohol-induced liver disease. Gastroenterologia 124:778-790
4. Balunas MJ, Kinghorn AD (2005) Drug discovery from medicinal plants. Life Sci 78:431-441
5. Bin G, Ramon B (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572-1585
6. Brocker C, Lassen N, Estey T et al (2010) Aldehyde dehydrogenase 7A1 (ALDH7-A1) is a novel enzyme involved in cellular defense against hyperosmotic Stress. J Biol Chem 285:18452-18463
7. Butler JA, Hagen TM, Moreau R (2009) Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch Biochem Biophys 485:63-71
8. Cai L (2008) Alcoholic cardiomyopathy: acetaldehyde, insulin insensitization and ER stress. J Mol Cell Cardiol 44:979-982
9. Cao Q, Mak KM, Lieber CS (2005) Cytochrome P4502E1 primes macrophages to increase TNF-alpha production in response to liposaccharide. Am J Physiol 289:G95-G107
10. Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C (2007) Nonalcohol fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 18:184-195
11. Cherian PP, Schenker S, Henderson GI (2008) Ethanol-mediated DNA damage and PARP-1 apoptotic responses in cultured fetal cortical neurons. Alcohol Clin Exp Res 32:1884-1892
12. Day CP (2006) Genes or environment to determine alcoholic liver disease and nonalcoholic fatty liver disease. Liver Int 26:1021-1028
13. Derdak Z, Lang CH, Villegas KA, Tong M, Mark NM, de la Monte SM, Wands JR (2011) Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J Hepatol 1:164-172
14. Ding RB, Tian K, Huang LL, He CW, Jiang Y, Wang YT, Wan JB (2012) Herbal medicines for the prevention of alcoholic liver disease: a review. J Ethnopharmacol 144:457-465
15. Dong H, Lu F, Zhao L (2012) Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. Chinese. J Integr Med 18:152-160
16. Emanuele A (2008) Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 29:9-16
17. Gavin A, Luis M, Christian M, Frederick B, Craig JM (2003) Advances in alcoholic liver disease. Best Pract Res Clin Gastroenterol 17:625-647
18. Giovanni M, Roberto G, Maurizio C (2009) Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48:1-26
19. Gnoni GV, Paglialonga G, Siculella L (2009) Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells. Eur J Clin Invest 39:761-768
20. Herbert T, Moschen AR, Kaneider NC (2011) Pathways of liver injury in alcoholic liver disease. J Hepatol 55:1159-1161
21. Hines IN, Wheeler MD (2004) Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol 287:G310-G314
22. Hoek JB, Pastorino JG (2002) Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 27:63-68
23. Hsieh MJ, Tsai TL, Hsieh YS, Wang CJ, Chiou HL (2013) Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3 K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines. Arch Toxicol In Press
24. Hu MM, Xu LN, Yin LH, Xu Y, Han X, Peng J, Wan X (2013) Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways. J Appl Toxicol 33:712-722
25. Jessica IC, Sanjoy R, Patricia MD, Jacobsen DW, Nagy LE (2009) Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 49:1709-1719
26. Ji C, Kaplowitz N (2003) Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124:1488-1499
27. Knight BL, Hebbachi A, Hauton D et al (2005) A role for PPAR-α in the control of SREBP activity and lipid synthesis in the liver. Biochem J 389:413-421
28. Kohjima M, Enjoji M, Higuchi N et al (2007) Revaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 20:351-358
29. Laurent M, Etienne B, Beatrice L et al (2011) ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytes. J Hepatol 54:729-737
30. Leung TM, Nieto N (2013) CYP2E1 and oxidant stress in alcoholic and non- alcoholic fatty liver disease. J Hepatol 58:395-398
31. Li SY, Ren J (2008) Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress. J Mol Cell Cardiol 44:992-1001
32. Li M, Han XW, Yu B (2003) Synthesis of monomethylated dioscin derivatives and their antitumor activities. Carbohydr Res 338:117-121
33. Li H, Huang W, Wen YQ, Gong GH, Zhao QB, Yu G (2010) Anti-thrombotic activity and chemical characterization of steroidal saponins from Dioscorea zingiberensis C.H. Wright. Fitoterapia 81:1147-1156
34. Lieber CS (2000) Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 32:113-128
35. Lu Y, Cederbaum AI (2008) CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44:723-738
36. 4-induced liver damage in mice. Planta Med 77:407-415
37. 4- induced acute liver damage in mice. Environ Toxicol Pharmacol 34:127-135
38. Lykkesfeldt J (2007) Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380:50-58
39. Mandrekar P, Szabo G (2009) Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50:1258-1266
40. Matsubara Y, Indo Y, Naito E, Ozasa H et al (1989) Molecular cloning and nucleotide sequence of cDNAs encoding the precursors of rat long chain acyl-coenzyme A, short chain acyl-coenzyme A, and isovaleryl-coenzyme A dehydrogenases. Sequence homology of four enzymes of the acyl-CoA dehydrogenase family. J Biol Chem 264:16321-16331
41. McVicker BL, Tuma DJ, Kubik JL, Tuma PL, Casey CA (2006) Ethanol-induced apoptosis in polarized hepatic cells possibly through regulation of the Fas pathway. Alcohol Clin Exp Res 30:1906-1915
42. Moriya T, Naito H, Ito Y, Nakajima T (2009) Hypothesis of seven balances: molecular mechanisms behind alcoholic liver diseases and association with PPAR alpha. J Occup Health 51:391-403
43. Nagy LE (2003) Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med 228:882-890
44. Nakajima T, Kamijo Y, Tanaka N et al (2004) Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 40:972-980
45. Nakamura T, Komori C, Lee Y et al (1996) Cytotoxic activities of solanum steroidal glycosides. Biol Pharm Bull 19:564-566
46. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ (2003) Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am J Physiol Gastrointest Liver Physiol 284:G321-G327
47. Pai JT, Guryev O, Brown MS, Goldstein JL (1998) Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins. J Biol Chem 273:26138-26148
48. Pana TL, Wanga PW, Leub YL, Wuc TH, Wud TS (2012) Inhibitory effects of Scutellaria baicalensis extract on hepatic stellate cells through inducing G2/M cell cycle arrest and activating ERK-dependent apoptosis via Bax and caspase pathway. J Ethnopharmacol 139:829-837
49. Pani G, Fusco S, Colavitti R, Borrello S, Maggiano N, Cravero AA (2004) Abrogation of hepatocyte apoptosis and early appearance of liver dysplasia in ethanol-fed p53-deficient mice. Biochem Biophys Res Commun 325:97-100
50. Pari L, Karthikesan K (2007) Protective role of caffeic acid against alcohol-induced biochemical changes in rats. Fundam Clin Pharmacol 21:355-361
51. Powel EE, Jonsson JR, Clouston AD (2005) Steatosis: co-factor in other liver diseases. Hepatology 42:5-13
52. Raj MD (2011) Adverse effects of corticosteroids on bone metabolism: a review. Phys Med Rehab 3:466-471
53. Ramsay RR, Richard DG, Feike RL (2001) Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 1546:21-43
54. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J (2009) Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373:2223-2233
55. Rosa LC, Moshagel H, Nieto N (2008) Hepatocyte oxidant stress and alcoholic liver disease. Rev Esp Enferm Dig 100:156-163
56. Schoonjans K, Staels B, Grimaldi P, Auwerx J (1993) Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. Eur J Biochem 216:615-622
57. Seth D, Haber PS, Syn WK, Diehl AM, Day CP (2011) Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol 26:1089-1105
58. Shen Z, Liang X, Rogers CQ, Rideout D, You M (2010) Involvement of adiponectin -SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 298:364-374
59. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL (1997) Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99:846-854
60. Song BJ, Moon KH, Olsson NU, Salem JN (2008) Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J Hepatol 49:262-273
61. Stewart SF, Day CP (2003) The management of alcoholic liver disease. J Hepatol 38:S2-S13
62. Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE (2006) Chronic ethanol feeding increases activation of NADPH oxidase by liposaccharide in rat Kuper cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukocyte Biol 79:1348-1356
63. VanGuilder HD, Vrana KE, Freeman WM (2008) Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44:619-626
64. Wagner M, Zollner G, Trauner M (2011) Nuclear receptors in liver disease. Hepatology 53:1023-1034
65. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE (2006) In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44:27-33
66. Xiong Y, Yang YQ, Yang J et al (2010) Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice. Toxicology 276:64-72
67. Xu TT, Zhang S, Zheng LL, Yin LH, Xu LN, Peng JY (2012) A 90-day subchronic toxicological assessment of dioscin, a natural steroid saponin, in Sprague-Dawley rats. Food Chem Toxicol 50:1279-1287
68. Yang MY, Peng CH, Chan KC, Yang YS, Huang CN, Wang CJ (2010) The hypolipidemic effect of Hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting hepatic lipid clearance. J Agric Food Chem 58:850-859
69. Yin HQ, Kim YC, Chung YS, Kim YC, Shin YK, Lee BH (2009) Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes. Toxicol Appl Pharmacol 236:124-130
70. Yin LH, Xu LN, Wang XN, Lu BN, Liu YT, Peng JY (2010a) An economical method for isolation of dioscin from Dioscorea nipponica Makino by HSCCC coupled with ELSD, and a computer-aided UNIFAC mathematical model. Chromatographia 71:15-23
71. Yin LH, Xu YS, Xu LN, Qi Y, Han X, Peng JY (2010b) A green and efficient protocol for industrial-scale preparation of dioscin from Dioscorea nipponica Makino by two-step macroporous resin column chromatography. Chem Eng J 165:281-289
72. Yip WW, Burt AD (2006) Alcoholic liver disease. Semin Diagn Pathol 23:149-160
73. Yu S, Rao S, Reddy JK (2003) Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med 3:561-572
74. Zeng T, Xie KQ (2009) Ethanol and liver: recent advances in the mechanisms of ethanol-induced hepatosteatosis. Arch Toxicol 83:1075-1081
75. Zhao XM, Cong XN, Zheng LL, Xu LN, Yin LH, Peng JY (2012) Dioscin, a natural steroid saponin, shows remarkable protective effect against acetaminophen-induced liver damage in vitro and in vivo. Toxicol Lett 214:69-80
76. Zoltan D, Charles HL, Kristine AV, Ming T, Nicholas MM, Suzanne MM, Jack RW (2011) Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J Hepatol 54:164-172